The size of the Infant Incubator Market in Latin America is projected to expand at a steady CAGR during the forecast period.
The increasing prevalence of preterm birth, lack of antenatal healthcare, and lack of medical facilities contribute to the Latin American infant incubator market. Neonates suffer from hypothermia, which represents a significant health problem. The World Health Organization (WHO) has reported that it is one of the leading causes of mortality and morbidity in newborns. According to the WHO, about 15.5 million babies are born prematurely, of which over 1 million deaths occur due to premature complications. According to the Oxford Academic Journal study, between 75% and 7% of babies suffer from hypothermia after birth. The increasing incidence of hypothermia has increased the demand for infant incubators that act as thermoregulatory devices, helping with maintaining constant viable temperature regulations.
Most newborns have neonatal jaundice, which increases the need for incubators with added features. Rapid technological advancements are expected to encourage companies to launch blue spectrum radiation sources and phototherapy devices, such as MTTS Firefly. Neonatal jaundice has seen positive results with adequate phototherapy in incubators. In addition, an increase in neonates with low birth weight and other conditions is increasing the demand for infant incubators across Latin America. The unmet need is most significant in common- and middle-income countries due to the increasing number of preterm births. For example, in Brazil, data from the National Live Birth System, following over 96% of all deliveries, the preterm birth prevalence was nearly 11.5% in 2016. Across Latin America in 2017, most countries are close to the regional average of 9.65% for preterm births. Colombia has the highest number of preterm births with an average of around 15.5%, followed by Brazil with over 11%. The lowest rates were observed in Cuba with 6.1%, and Mexico was reported with 7%. Hence, the demand for neonatal/infant incubators is expected to grow while driving the Latin American infant incubator market.
However, the high cost of incubators is the main factor responsible for hampering the market growth. In addition, it is accompanied by the lack of adequate guidelines regarding the design and operation of platelet incubators, making it difficult to market. This has been observed primarily in underdeveloped and developing countries. Furthermore, other factors, such as the lack of awareness about maternity health and antenatal health among the populations, are also challenging the growth of the Latin American infant incubator market.
Over the forecast period, Mexico is expected to register a high market share in the Latin American region. This regional market growth can be attributed to the growing number of premature term babies, increasing medical expenditure, improving healthcare infrastructure, and government initiatives for awareness. In 2018, 425,600 births were registered, out of which 9.8% or nearly 41,800 were reported to be premature infants with less than 37 weeks gestational age, and over 7,500 or 1.8% weighed less than 1,500 g. According to the Centers for Disease Control and Prevention (CDC), about 1 in 10 babies was born too early. These high numbers of preterm births in the region will increase the demand for infant incubator devices in the years to come.
Brazil is expected to be the second leading region in the Latin American infant incubator market. Furthermore, it is observed that the number of premature births in Italy exceeds 7% and is expected to increase over the years, contributing to the growth of the market. The increasing number of premature babies, the presence of key manufacturers, and the availability of advanced technologies are the factors that are contributing to the market growth. In addition, the government's increased efforts to provide affordable health care offer lucrative opportunities for market growth.
Companies playing a noteworthy role in the Latin America Infant Incubator Market profiled in this report are GE Healthcare, Novos Medical Systems, Atom Medical Corporation, Ningbo David Medical Device Co., Ltd, Natus Medical Incorporated, Fanem Ltd, Cobams SRL, AVI Healthcare Private Limited, Gammer International, and Ardo.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region